Open main menu
Search Ctrl + K
Sign up for free
Loading...
Pacira Biosciences, Inc.
Watch
Pharmaceutical Preparations
NASDAQ.PCRX
5401 West Kennedy Boulevard, Suite 890, Tampa, FL, 33609
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Prospectuses and Registrations
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
29 Feb 24
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
02 Aug 23
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
04 Aug 22
SC TO-T/A
Amended Tender Offer Statement By Third Party.
19 Nov 21
SC TO-T/A
Amended Tender Offer Statement By Third Party.
18 Nov 21
SC TO-T/A
Amended Tender Offer Statement By Third Party.
12 Nov 21
SC TO-T/A
Amended Tender Offer Statement By Third Party.
01 Nov 21
News
8-K
Other Events, Financial Statements And Exhibits
09 Aug 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
30 Jul 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Submission Of Matters To A Vote Of Security Holders
13 Jun 24
8-K
Entry Into A Material Definitive Agreement, Creation Of A Direct Financial Obligation Or An Obligation Under An Off-balance Sheet Arrangement Of A Registrant, Unregistered Sales Of Equity Securities, Other Events, Financial Statements And Exhibits
14 May 24
8-K
Entry Into A Material Definitive Agreement, Creation Of A Direct Financial Obligation Or An Obligation Under An Off-balance Sheet Arrangement Of A Registrant, Other Events, Financial Statements And Exhibits
08 May 24
8-K
Results Of Operations And Financial Condition, Other Events, Financial Statements And Exhibits
07 May 24
8-K
Results Of Operations And Financial Condition, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits
29 Feb 24
Financials
10-Q
Quarterly Filing
30 Jul 24
10-Q
Quarterly Filing
07 May 24
10-K
Fiscal Year 2024
29 Feb 24
10-Q
Quarterly Filing
02 Nov 23
10-Q
Quarterly Filing
02 Aug 23
10-Q
Quarterly Filing
03 May 23
10-K
Fiscal Year 2022
28 Feb 23
Other
ARS
Scanned Paper Annual Report Submission.
22 Apr 24
UPLOAD
Letter From The Sec.
24 Oct 23
CORRESP
Correspondence With The Sec.
06 Oct 23
UPLOAD
Letter From The Sec.
22 Sep 23
ARS
Scanned Paper Annual Report Submission.
21 Apr 23
CT ORDER
Confidential Treatment Order By The Sec.
17 Aug 20
CT ORDER
Confidential Treatment Order By The Sec.
10 Apr 20
Ownership
4
Brege Laura
19 Aug 24
4
Bigal Marcelo
19 Aug 24
4
Yang Michael J.
14 Aug 24
4/A
Bigal Marcelo
13 Aug 24
4
Lee Frank D.
13 Aug 24
4
Froimson Mark
12 Aug 24
4
Bigal Marcelo
12 Aug 24
Proxies
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
22 Apr 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
22 Apr 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
21 Apr 23
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
21 Apr 23
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
22 Apr 22
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
22 Apr 22
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
22 Apr 21